Clinical Trial Update: Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating sonodynamic therapy with SONALA-001 or 5-ALA HCl combined with MRI-guided focused ultrasound for progressive or recurrent …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 5-ALA HCl (5-aminolevulinic acid hydrochloride)
• SONALA-001

Snippet

Sponsor: Mayo Clinic | Conditions: Progressive Glioblastoma, Recurrent Glioblastoma | EARLY_Phase 1 | Status: RECRUITING